Corbus Pharmaceuticals Holdings Inc
CRBP8.149USD
+0.029+0.35%
Market hours （ET）Quotes delayed by 15 min
102.14MMarket Cap
LossP/E TTM
Corbus Pharmaceuticals Holdings Inc Earnings Date
Period
FY2024 Earnings Date
Revenue(YoY)
--
--
EPS(YoY)
-3.68
64.26%
Analyst Rating
BUY
2025-12-09
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What is the total revenue of Corbus Pharmaceuticals Holdings Inc?
According to Corbus Pharmaceuticals Holdings Inc's FY2024 earnings report, its total revenue reached --, with a year-on-year change of --.
What is the Earnings Per Share (EPS) of Corbus Pharmaceuticals Holdings Inc?
According to Corbus Pharmaceuticals Holdings Inc's FY2024 earnings report, its Earnings Per Share (EPS) was -3.684, with a year-on-year change of 64.26%.
What is the net income of Corbus Pharmaceuticals Holdings Inc?
According to Corbus Pharmaceuticals Holdings Inc's FY2024 earnings report, its net income was -40.21M, with a year-on-year change of 9.85%.
What is the net margin of Corbus Pharmaceuticals Holdings Inc?
According to Corbus Pharmaceuticals Holdings Inc's FY2024 earnings report, its net profit margin was --, with a year-on-year change of --.
What is the gross margin of Corbus Pharmaceuticals Holdings Inc?
According to Corbus Pharmaceuticals Holdings Inc's FY2024 earnings report, its gross margin was --, with a year-on-year change of --.
What is the debt-to-asset ratio of Corbus Pharmaceuticals Holdings Inc?
According to Corbus Pharmaceuticals Holdings Inc's FY2024 earnings report, its debt-to-asset ratio was --, with a year-on-year change of -100.00%.
What is the Return on Equity (ROE) of Corbus Pharmaceuticals Holdings Inc?
According to Corbus Pharmaceuticals Holdings Inc's FY2024 earnings report, its Return on Equity (ROE) was -59.34%, with a year-on-year change of 82.65%.
What is the Return on Assets (ROA) of Corbus Pharmaceuticals Holdings Inc?
According to Corbus Pharmaceuticals Holdings Inc's FY2024 earnings report, its Return on Assets (ROA) was -43.67%, with a year-on-year change of 53.70%.
What is the operating profit of Corbus Pharmaceuticals Holdings Inc?
According to Corbus Pharmaceuticals Holdings Inc's FY2024 earnings report, its operating profit was -48.72M, with a year-on-year change of -8.08%.
What are the current assets of Corbus Pharmaceuticals Holdings Inc?
According to Corbus Pharmaceuticals Holdings Inc's FY2024 earnings report, its current assets were 152.98M, with a year-on-year change of 549.69%.
What are the total assets of Corbus Pharmaceuticals Holdings Inc?
According to Corbus Pharmaceuticals Holdings Inc's FY2024 earnings report, its total assets of Corbus Pharmaceuticals Holdings Inc were 155.88M, with a year-on-year change of 451.35%.
What are the total liabilities of Corbus Pharmaceuticals Holdings Inc?
According to Corbus Pharmaceuticals Holdings Inc's FY2024 earnings report, its total liabilities of Corbus Pharmaceuticals Holdings Inc were 13.45M, with a year-on-year change of -61.76%.
What is the total equity of Corbus Pharmaceuticals Holdings Inc?
According to Corbus Pharmaceuticals Holdings Inc's FY2024 earnings report, its total equity of Corbus Pharmaceuticals Holdings Inc was 142.43M, with a year-on-year change of 2162.76%.
What is the net operating income of Corbus Pharmaceuticals Holdings Inc?
According to Corbus Pharmaceuticals Holdings Inc's FY2024 earnings report, its net operating income of Corbus Pharmaceuticals Holdings Inc was -40.21M, with a year-on-year change of 9.85%.
What is the net investment of Corbus Pharmaceuticals Holdings Inc?
According to Corbus Pharmaceuticals Holdings Inc's FY2024 earnings report, its net investment of Corbus Pharmaceuticals Holdings Inc was -121.31M, with a year-on-year change of -440.36%.
What is the net financing of Corbus Pharmaceuticals Holdings Inc?
According to Corbus Pharmaceuticals Holdings Inc's FY2024 earnings report, its net financing of Corbus Pharmaceuticals Holdings Inc was 166.58M, with a year-on-year change of 6005.93%.
